M A Bertocci1, G Bebko1, A Versace1, S Iyengar2, L Bonar1, E E Forbes1, J R C Almeida1, S B Perlman1, C Schirda1, M J Travis1, M K Gill1, V A Diwadkar3, J L Sunshine4, S K Holland5, R A Kowatch6, B Birmaher1, D A Axelson6, T W Frazier7, L E Arnold6, M A Fristad6, E A Youngstrom8, S M Horwitz9, R L Findling10, M L Phillips1. 1. Department of Psychiatry,Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, University of Pittsburgh,Pittsburgh, PA,USA. 2. Department of Statistics,University of Pittsburgh,Pittsburgh, PA,USA. 3. Department of Psychiatry and Behavioral Neuroscience,Wayne State University,Detroit, MI,USA. 4. Department of Radiology,University Hospitals Case Medical Center/Case Western Reserve University,Cleveland, OH,USA. 5. Cincinnati Children's Hospital Medical Center, University of Cincinnati,Cincinnati, OH,USA. 6. Department of Psychiatry and Behavioral Health,Ohio State University,Columbus, OH,USA. 7. Pediatric Institute,Cleveland Clinic,Cleveland, OH,USA. 8. Department of Psychology,University of North Carolina at Chapel Hill,Chapel Hill, NC,USA. 9. Department of Child and Adolescent Psychiatry,New York University School of Medicine,New York, NY,USA. 10. Department of Psychiatry,Johns Hopkins University,Baltimore, MD,USA.
Abstract
BACKGROUND: Identifying youth who may engage in future substance use could facilitate early identification of substance use disorder vulnerability. We aimed to identify biomarkers that predicted future substance use in psychiatrically un-well youth. METHOD: LASSO regression for variable selection was used to predict substance use 24.3 months after neuroimaging assessment in 73 behaviorally and emotionally dysregulated youth aged 13.9 (s.d. = 2.0) years, 30 female, from three clinical sites in the Longitudinal Assessment of Manic Symptoms (LAMS) study. Predictor variables included neural activity during a reward task, cortical thickness, and clinical and demographic variables. RESULTS: Future substance use was associated with higher left middle prefrontal cortex activity, lower left ventral anterior insula activity, thicker caudal anterior cingulate cortex, higher depression and lower mania scores, not using antipsychotic medication, more parental stress, older age. This combination of variables explained 60.4% of the variance in future substance use, and accurately classified 83.6%. CONCLUSIONS: These variables explained a large proportion of the variance, were useful classifiers of future substance use, and showed the value of combining multiple domains to provide a comprehensive understanding of substance use development. This may be a step toward identifying neural measures that can identify future substance use disorder risk, and act as targets for therapeutic interventions.
BACKGROUND: Identifying youth who may engage in future substance use could facilitate early identification of substance use disorder vulnerability. We aimed to identify biomarkers that predicted future substance use in psychiatrically un-well youth. METHOD: LASSO regression for variable selection was used to predict substance use 24.3 months after neuroimaging assessment in 73 behaviorally and emotionally dysregulated youth aged 13.9 (s.d. = 2.0) years, 30 female, from three clinical sites in the Longitudinal Assessment of Manic Symptoms (LAMS) study. Predictor variables included neural activity during a reward task, cortical thickness, and clinical and demographic variables. RESULTS: Future substance use was associated with higher left middle prefrontal cortex activity, lower left ventral anterior insula activity, thicker caudal anterior cingulate cortex, higher depression and lower mania scores, not using antipsychotic medication, more parental stress, older age. This combination of variables explained 60.4% of the variance in future substance use, and accurately classified 83.6%. CONCLUSIONS: These variables explained a large proportion of the variance, were useful classifiers of future substance use, and showed the value of combining multiple domains to provide a comprehensive understanding of substance use development. This may be a step toward identifying neural measures that can identify future substance use disorder risk, and act as targets for therapeutic interventions.
Entities:
Keywords:
Functional magnetic resonance imaging; GLMNET; LASSO; substance use; youth
Authors: M A Bertocci; G Bebko; A Versace; J C Fournier; S Iyengar; T Olino; L Bonar; J R C Almeida; S B Perlman; C Schirda; M J Travis; M K Gill; V A Diwadkar; E E Forbes; J L Sunshine; S K Holland; R A Kowatch; B Birmaher; D Axelson; S M Horwitz; T W Frazier; L E Arnold; M A Fristad; E A Youngstrom; R L Findling; M L Phillips Journal: Mol Psychiatry Date: 2016-02-23 Impact factor: 15.992
Authors: Omid Kohannim; Derrek P Hibar; Jason L Stein; Neda Jahanshad; Xue Hua; Priya Rajagopalan; Arthur W Toga; Clifford R Jack; Michael W Weiner; Greig I de Zubicaray; Katie L McMahon; Narelle K Hansell; Nicholas G Martin; Margaret J Wright; Paul M Thompson Journal: Front Neurosci Date: 2012-08-06 Impact factor: 4.677
Authors: Caroline W Oppenheimer; Michele Bertocci; Tsafrir Greenberg; Henry W Chase; Richelle Stiffler; Haris A Aslam; Jeanette Lockovich; Simona Graur; Genna Bebko; Mary L Phillips Journal: Psychiatry Res Neuroimaging Date: 2021-09-03 Impact factor: 2.376
Authors: Briana Lees; Alexis M Garcia; Jennifer Debenham; Anna E Kirkland; Brittany E Bryant; Louise Mewton; Lindsay M Squeglia Journal: Neuropharmacology Date: 2021-02-16 Impact factor: 5.250
Authors: D Cutuli; D Ladrón de Guevara-Miranda; E Castilla-Ortega; L J Santín; P Sampedro-Piquero Journal: Curr Neuropharmacol Date: 2019 Impact factor: 7.363